tradingkey.logo

Sarepta Therapeutics Announces Pipeline Progress For Multiple Limb-Girdle Muscular Dystrophy Programs

ReutersApr 15, 2025 1:37 PM

- Sarepta Therapeutics Inc SRPT.O:

  • SAREPTA THERAPEUTICS ANNOUNCES PIPELINE PROGRESS FOR MULTIPLE LIMB-GIRDLE MUSCULAR DYSTROPHY PROGRAMS

  • SAREPTA THERAPEUTICS INC: DATA EXPECTED FOR SRP-9003 FOR LGMD2E/R4 BY MID-2025

  • SAREPTA THERAPEUTICS INC: U.S. FDA HAS CONFIRMED THAT SCREENING AND DOSING MAY PROCEED IN STUDY SRP-9005-101 FOR LGMD2C/R5

  • SAREPTA THERAPEUTICS INC: ENROLLMENT AND DOSING COMPLETED IN STUDY SRP-9004-102 FOR LGMD2D/R3

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI